Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond

Outcomes for pediatric patients with acute myeloid leukemia (AML) remain poor, highlighting the need for improved targeted therapies. Building on the success of CD19-directed immune therapy for acute lymphocytic leukemia (ALL), efforts are ongoing to develop similar strategies for AML. Identifying t...

Descripción completa

Detalles Bibliográficos
Autores principales: Epperly, Rebecca, Gottschalk, Stephen, Velasquez, Mireya Paulina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072334/
https://www.ncbi.nlm.nih.gov/pubmed/32079207
http://dx.doi.org/10.3390/children7020014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072334/
https://www.ncbi.nlm.nih.gov/pubmed/32079207
http://dx.doi.org/10.3390/children7020014

Ejemplares similares